Abstract: In a mobile communication system including a plurality of RATs (Radio Access Technologies), the necessity of a control channel for notifying RAT information is eliminated, and the lack of capacity of the control channel can be avoided. In a mobile station 30 communicating with base stations employing the different RATs by employing the respective RATs, when the mobile station executes procedures for registration to an LTE (Long-term evolution) base station 10-2 which allows access to only registered mobile stations that are registered in advance, the mobile station obtains, from a HSS (Home Subscriber Server) 40 tied to the LTE base station 10-2, information of another base station that performs communication by employing the RAT different from that used by the LTE base station 10-2.
Abstract: The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
Abstract: This liquid crystal display panel (100A) includes: first and second substrates (10A, 20A) which are arranged to face each other with a liquid crystal layer (30A) interposed between them; a counter electrode (24) formed on one of the first and second substrates (10A, 20A); a first alignment film (16a) formed on one side of the first substrate (10A) to face the liquid crystal layer (30A); and a second alignment film (26a) formed on one side of the second substrate (20A) to face the liquid crystal layer (30A). In a pixel, the liquid crystal layer (30A) has a low-pretilt region (R1a) and a high-pretilt region (R2a) in which liquid crystal molecules (32) have mutually different pretilt angles. The counter electrode (24) includes a plurality of sub-counter electrodes which are electrically independent of each other.
Abstract: A cleaning robot (1) which is an autonomous mobile system performs coordinate conversion of three-dimensional coordinate data acquired by measurement in a distance image sensor (20) which is arranged in a frontward and obliquely downward direction to generate three-dimensional coordinate data of a floor surface reference. Labels are applied to this data by judging a level difference or an obstacle according to height from a floor surface (F) to create overhead view image data seen from directly above a cleaning robot main body. The overhead view image data is scanned, and only when the labels are arranged in a specific order, processing for substituting an unspecified area with a level difference is performed. Thereby, positional deviation of an edge of the level difference, which is caused by a blind spot, is corrected and a position of the level difference is able to be grasped accurately.
Abstract: This portable terminal has disposed therein: a circuit board (14), which is disposed in a cabinet (15), and which has an electronic component (14a) mounted thereon; a display panel (11) disposed on the open plane of the cabinet (15); and a rechargeable battery (12) disposed between the display panel (11) and the circuit board (14).
Abstract: Provided is a control station device that is capable of using an easy scheduling scheme in spectrum-overlapped resource management. The control station device, which allocates a frequency band which multiple communication apparatuses each use for communication, includes a group setting module that divides the multiple communication apparatuses into multiple groups and a scheduling module that determines the frequency band that is allocated to each of the communication apparatuses. In the control station device, the scheduling module allows the allocated frequency band to be shared by the communication apparatuses that are different from each other in terms of the group to which each of the communication apparatuses belongs.
Abstract: The present invention relates to 5?-Substituted Nucleoside Analogs of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, Z, R1, R2, R3 and R3? are as defined herein. The present invention also relates to compositions comprising at least one 5?-Substituted Nucleoside Analog, and methods of using the 5?-Substituted Nucleoside Analogs for treating or preventing HCV infection in a patient.
Type:
Grant
Filed:
July 10, 2012
Date of Patent:
August 9, 2016
Assignee:
Merck Sharp & Dohme Corp.
Inventors:
Vishal A. Verma, Ashok Arasappan, F. George Njoroge, Kevin X. Chen
Abstract: A mobile terminal apparatus includes a geometrical arrangement detecting section (111) detecting groups of edge pixels arranged in a shape of a line segment in an image captured by an image-capturing apparatus; and a display processing section (112) causes a contour line representative of a contour of a rectangular captured object to be displayed on the captured image displayed on a display section so that the contour line is superimposed on the groups of edge pixels detected by the geometrical arrangement detecting section (111).
Abstract: A semiconductor phosphor nanoparticle includes a semiconductor nanoparticle and a first organic compound. An end of the first organic compound is bonded to a surface of the semiconductor nanoparticle, and the other end of the first organic compound is polymerized to form a first inorganic layer.
Abstract: A mobile station is provided to which multimedia broadcast/multicast service can be applied also during carrier aggregation. A mobile station communicates with a base station by carrier aggregation using a plurality of component carriers having different frequency bands. The mobile station receives contents in MBMS from the base station using at least two component carriers of a plurality of component carriers. The mobile station causes a display to display the received contents.
Abstract: This liquid crystal display device (100) includes: a vertical alignment liquid crystal layer (3); a pixel electrode (11) and a counter electrode (21) arranged on first and second substrates (1, 2), respectively, to front on the liquid crystal layer; and first and second alignment films (12, 22). Each pixel region (10) includes first, second, third and fourth liquid crystal domains (A, B, C, D) in which liquid crystal molecules (3a) are tilted in first, second, third and fourth predetermined directions, respectively, which are defined so that an angle formed between any two of them is approximately equal to an integral multiple of 90 degrees. The first liquid crystal domain is located close to at least a part of edges of the pixel electrode, which includes a first edge portion (EG1) where an azimuthal direction (e1) perpendicular to the part and pointing toward the inside of the pixel electrode defines an angle greater than 90 degrees to the first direction.
Abstract: The present invention is directed to piperidinone carboxamide spirohydantoin derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Abstract: A phosphor nanoparticle includes a nanoparticle core composed of a compound semiconductor, a shell layer that covers the nanoparticle core, and a modifying organic compound bound to the outer surface of the shell layer. The modifying organic compound exhibits absorption in at least part of a wavelength range of 300 nm or more and 400 nm or less.
Abstract: A drive device of the present invention includes a VCOM selection circuit (122) for switching, before a display panel (102) is turned off, an electric potential of a counter electrode COM of each of pixels P from a VCOM1 to a VCOM2 which causes an electric potential of a drain electrode of each of the pixel P to be identical to the electric potential of the counter electrode COM after the display panel (102) is turned off.
Abstract: In its many embodiments, the present invention provides certain C5-spiro iminothiadiazine dioxide compounds, including compounds Formula (I): or a tautomers and/or stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomers and said stereoisomers, wherein RL, X, Y, R1A, R1B, R2, R3, m, and RA are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.
Type:
Application
Filed:
September 8, 2014
Publication date:
August 4, 2016
Applicant:
Merck Sharp & Dohme Corp.
Inventors:
Jack D. Scott, Wen-Lian Wu, Jared N. Cumming
Abstract: This invention relates to a method for decoding video comprising: (a) receiving a video bitstream of encoded pictures, wherein said video bitstream includes a plurality of layers; and (b) receiving chromaticity information related to said video bitstream, wherein said chromaticity information includes (1) one or more sets of information on said video signal; (2) the number of said set of said information on said video signal; (3) an index of said information on said video signal; and (4) a flag which indicates whether or not said number and said index are present.
Abstract: Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
Type:
Application
Filed:
September 10, 2014
Publication date:
August 4, 2016
Applicants:
Merck Sharp & Dohme Corp., Lawrence Livermore National Security, LLC
Inventors:
John Finn, Leslie William Tari, Zhiyong Chen, Junhu Zhang, Douglas Phillipson, Suk Joong Lee, Michael Trzoss, Daniel Bensen, Xiaoming Li, Min Teng, Voon Ong, Allen John Borchardt, Thanh To Lam, Felice C. Lightstone, Sergio E. Wong, Toan B. Nguyen
Abstract: The instant invention relates to liquid pharmaceutical compositions containing CGRP receptor antagonists. The CGRP receptor antagonist liquid pharmaceutical compositions of the instant invention are alcohol-free, low volume liquid pharmaceutical compositions that can be taken without water for the treatment of migraine headache.
Type:
Application
Filed:
September 11, 2014
Publication date:
August 4, 2016
Applicant:
Merck Sharp & Dohme Corp.
Inventors:
Majid Mahjour, Leonardo R. Allain, Sutthilug Sotthivirat, Russell G. Maus, Rebecca Nofsinger, Lisa Lupton, Wei Xu, Francis Flanagan
Abstract: A mobile station (MS) receives, from a base station (BS), information which is used to assign a PUSCH resource; transmits uplink control information using a single PUCCH resource in case that the PUSCH resource is not assigned and a plurality of PUCCH resources is assigned; transmits the uplink control information using the PUSCH resource assigned on a first uplink component carrier (UCC) in case that the PUSCH resource is assigned on the first UCC, the first UCC is used for transmitting the uplink control information using the single PUCCH resource in case that the PUSCH resource is not assigned and the plurality of PUCCH resources is assigned; and receives the uplink control information using the PUSCH resource assigned on a second UCC in case that the PUSCH resource is not assigned on the first UCC but the PUSCH resource is assigned on the second UCC.
Abstract: A measuring device (9) of the present invention includes a detector control module (31) for obtaining, from a scanning mechanism including an excitation light source (4) for emitting excitation light and a detector (8) for receiving fluorescence generated from the measurement target upon irradiation with the excitation light, measurement data of the fluorescence, a position information obtaining module (32) for obtaining, from a driving mechanism for controlling relative positions of the scanning mechanism and the measurement target, information of a position where the measurement target is irradiated with the excitation light when the measurement data is obtained, and a fluorescence characteristic management module (33) for preparing fluorescence characteristic data including the measurement data and the position information.